BDBM489628 4-((1R)-3-(8-(4-amino- 8-fIuoro-6,7-dimethoxy- quinazolin-2-yl)-3,8- diazabicyclo[3.2.1]- octan-3-yl)-1-(ethyl- amino)-3-oxopropyl)- benzonitrile::US10961252, Cmp No. 16::US11248000, Cmp No. 16

SMILES CCN[C@H](CC(=O)N1CC2CCC(C1)N2c1nc(N)c2cc(OC)c(OC)c(F)c2n1)c1ccc(cc1)C#N

InChI Key InChIKey=DSSPYTCEKXAOAQ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 489628   

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489628(US10961252, Cmp No. 16 | 4-((1R)-3-(8-(4-amino- 8-...)
Affinity DataIC50: 1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetComplement factor B(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489628(US10961252, Cmp No. 16 | 4-((1R)-3-(8-(4-amino- 8-...)
Affinity DataIC50: 1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2021
Entry Details
US Patent